Identification of the abnormalities in astrocytic functions as potential drug targets for neurodegenerative disease

Valtteri Syvänen, Jari Koistinaho, Šárka Lehtonen

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review


Introduction: Historically, astrocytes were seen primarily as a supportive cell population within the brain; with neurodegenerative disease research focusing exclusively on malfunctioning neurons. However, astrocytes perform numerous tasks that are essential for maintenance of the central nervous system`s complex processes. Disruption of these functions can have negative consequences; hence, it is unsurprising to observe a growing amount of evidence for the essential role of astrocytes in the development and progression of neurodegenerative diseases. Targeting astrocytic functions may serve as a potential disease-modifying drug therapy in the future. Areas covered: The present review emphasizes the key astrocytic functions associated with neurodegenerative diseases and explores the possibility of pharmaceutical interventions to modify these processes. In addition, the authors provide an overview of current advancement in this field by including studies of possible drug candidates. Expert opinion: Glial research has experienced a significant renaissance in the last quarter-century. Understanding how disease pathologies modify or are caused by astrocyte functions is crucial when developing treatments for brain diseases. Future research will focus on building advanced models that can more precisely correlate to the state in the human brain, with the goal of routinely testing therapies in these models.

TidskriftExpert opinion on drug discovery
Antal sidor14
StatusPublicerad - 2024
MoE-publikationstypA2 Granska artikel i en vetenskaplig tidskrift

Bibliografisk information

Publisher Copyright:
© 2024 Informa UK Limited, trading as Taylor & Francis Group.


  • 3112 Neurovetenskaper

Citera det här